RSC Advances
Communication
showed significant chemical shifts of the carbon atoms around
the carboxylate functions proving the complexation of the
lanthanide with the seven ligands. Finally hydration numbers
have been calculated for luminescent Eu3+ complexes 1b and 2b
by using the well-established isotope effect and the Horrocks
After complexometric titration using EDTA in the presence of
xylenol orange as an indicator, weak percentages of 0.6% of free
Gd(III) for 1a and of 0.4% of free Eu(III) for 2b were measured
validating the MRI results observed.
equation (ESI ). Indeed the comparison of the luminescence
3
Conclusions
lifetimes of these europium complexes obtained in H2O and D2O
allows an assessment of the hydration state. Hydration numbers
of 2.48 and 2.18 were obtained for 1b and 2b, respectively, and
confirm the presence of heptacoordinated active sites.
In summary, we developed a new synthetic method using allylic
functions to access to C6-functionalized CDs that enlarge the
panel of known selective protections and can be a solution to solve
the common problem of weak solubility in organic solvents of
these scaffolds.
The MRI results obtained with two new CAs confirmed the
potential of this strategy for relaxation enhancement using
polydentate hydrophilic CDs as new imaging tools. A comparative
study underlined the individual contributions of the rim of CD on
the MRI signal and allowed the first quantification of the positive
influence of the second coordination shell of the CD. The relaxivity
gain could be attributed to a high number of water molecules
being involved in a network of hydrogen bonding interactions.
A nuclear magnetic relaxation dispersion profile (NMRD)
measurement will pinpoint the respective roles of the three
hydration spheres contributions (inner, second and outer
coordination spheres).
MRI tests were carried out at 0.5 Tesla on minispec mq 20 in
TRIS buffer under physiological pH and at 37 uC. The relaxivities
(r1) of 1a and 2a CAs were 4.56 and 6.53 mM21 s21 respectively.
These results correspond to an increase of 30% and 87% of the
signal imaging compared to the reference value of DOTA (Chart 1).
This variation observed between DOTA and CAs 1a–2a could be
explained by a higher molecular size of the CD scaffold increasing
the reorientational correlation times (tr) and consequently the
relaxivities.3 Nevertheless the high signal variation of 43% between
CAs 1a and 2a is mainly due to the second coordination sphere
effect because the variation of mass between the adducts here is
negligible.15 Indeed 2a may yield stronger interactions with water
molecules on the upper face of the macrocycle, and lengthens
their lifetime rate in the proximity of the paramagnetic centre.
Such hydrogen-bonding networks involving the coordinated
water(s) are then reinforced and perturb the relaxivity.16 In order to
reduce the water molecules around the complexes and present in
the cavity of the macrocycle, dioxane was selected due to its high
miscibility with water and its slow self-diffusion.17 A similar drop
Acknowledgements
We are grateful to Haute-Normandie Region via the FEDER for
the post-doctoral fellowship (I. Z.), the French Ministry of
Research for the PhD grant (H. I.), Interreg AIChem for the
PhD grant (A.B.), OSEO, SEINARI, and the Institute for
Research and Innovation in Biomedicine of Rouen for their
financial supports.
of the relaxivities for 1a and 2a at 2.2 mM21s21 and 2.5 mM21s21
,
respectively, was observed proving the key role of the outersphere
for these two complexes.
Water molecules around 1a and 2a complexes may present
different rotational mobilities due to the distortion of the shape of
the CD slowing down the dynamics of rotation and enhancing the
contrast imaging.
Notes and references
As the presence of free Gd3+ in CAs may have no negligible
impact on the contrast in the MR image and could provide
erroneous information on the contrast effect induced, a titration
has been carried out following the protocol described by Barge.18
1 (a) P. Caravan, J. J. Ellison, T. J. McMurry and R. B. Lauffer,
Chem. Rev., 1999, 99, 2293–2352; (b) S. Aime, M. Botta and
E. Terreno, Adv. Inorg. Chem., 2005, 57, 173–237; (c) K.
H. Thompson and C. Orvig, Chem. Soc. Rev. Special issue,
2006, 35, 500–571.
´
2 (a) J.-M. Idee, M. Port, I. Raynal, M. Schaefer, S. Le Greneur and
C. Corot, Fundam. Clin. Pharmacol., 2006, 20, 563–576; (b) J.-
´
M. Idee, M. Port, C. Medina, E. Lancelot, E. Fayoux, S. Ballet
and C. Corot, Toxicology, 2008, 248, 77–88; (c) M. Port, J.-
´
M. Idee, C. Medina, C. Robic, M. Sabatou and C. Corot,
BioMetals, 2008, 21, 469–490.
3 (a) Y. Song, E. K. Kohlmeir and T. J. Meade, J. Am. Chem. Soc.,
2008, 130, 6662–6663; (b) J. M. Bryson, W. J. Chu, J. H. Lee and
T. M. Reineke, Bioconjugate Chem., 2008, 19, 1505–1509; (c) C.
S. Bonnet, P. H. Fries, A. Gadelle, S. Gambarelli and P. Delangle,
J. Am. Chem. Soc., 2008, 130, 10401–10413; (d) Z. Kotkova,
J. Kotek, D. Jirak, P. Jendelova, V. Herynek, Z. Berkova,
P. Hermann and I. Lukes, Chem.–Eur. J., 2010, 16, 10094–10102.
4 V. T. D’Souza, Chem. Rev., 1998, 98, 1741–2076.
5 Cerius 2, Version 4.9, 2003, Accelrys Inc.
6 G. Yi, J. S. Bradshaw, B. E. Rossiter, S. L. Reese, P. Petersson, K.
E. Markides and M. L. Lee, J. Org. Chem., 1993, 58, 2561–2565.
Chart 1 Comparison of MRI results between DOTA, 1a and 2a.
This journal is ß The Royal Society of Chemistry 2013
RSC Adv., 2013, 3, 4531–4534 | 4533